302 related articles for article (PubMed ID: 25772243)
1. GPNMB cooperates with neuropilin-1 to promote mammary tumor growth and engages integrin α5β1 for efficient breast cancer metastasis.
Maric G; Annis MG; Dong Z; Rose AA; Ng S; Perkins D; MacDonald PA; Ouellet V; Russo C; Siegel PM
Oncogene; 2015 Oct; 34(43):5494-504. PubMed ID: 25772243
[TBL] [Abstract][Full Text] [Related]
2. GPNMB augments Wnt-1 mediated breast tumor initiation and growth by enhancing PI3K/AKT/mTOR pathway signaling and β-catenin activity.
Maric G; Annis MG; MacDonald PA; Russo C; Perkins D; Siwak DR; Mills GB; Siegel PM
Oncogene; 2019 Jun; 38(26):5294-5307. PubMed ID: 30914799
[TBL] [Abstract][Full Text] [Related]
3. The laminin-derived peptide C16 regulates GPNMB expression and function in breast cancer.
Smuczek B; Santos ES; Siqueira AS; Pinheiro JJV; Freitas VM; Jaeger RG
Exp Cell Res; 2017 Sep; 358(2):323-334. PubMed ID: 28689015
[TBL] [Abstract][Full Text] [Related]
4. A monoclonal antibody targeting neuropilin-1 inhibits adhesion of MCF7 breast cancer cells to fibronectin by suppressing the FAK/p130cas signaling pathway.
Zeng F; Luo F; Lv S; Zhang H; Cao C; Chen X; Wang S; Li Z; Wang X; Dou X; Dai Y; He M; Zhang Y; Lv H; Yan J; Chen Y
Anticancer Drugs; 2014 Jul; 25(6):663-72. PubMed ID: 24583771
[TBL] [Abstract][Full Text] [Related]
5. Glycoprotein nonmetastatic B is an independent prognostic indicator of recurrence and a novel therapeutic target in breast cancer.
Rose AA; Grosset AA; Dong Z; Russo C; Macdonald PA; Bertos NR; St-Pierre Y; Simantov R; Hallett M; Park M; Gaboury L; Siegel PM
Clin Cancer Res; 2010 Apr; 16(7):2147-56. PubMed ID: 20215530
[TBL] [Abstract][Full Text] [Related]
6. ADAM10 releases a soluble form of the GPNMB/Osteoactivin extracellular domain with angiogenic properties.
Rose AA; Annis MG; Dong Z; Pepin F; Hallett M; Park M; Siegel PM
PLoS One; 2010 Aug; 5(8):e12093. PubMed ID: 20711474
[TBL] [Abstract][Full Text] [Related]
7. Neuropilin-1/GIPC1 signaling regulates alpha5beta1 integrin traffic and function in endothelial cells.
Valdembri D; Caswell PT; Anderson KI; Schwarz JP; König I; Astanina E; Caccavari F; Norman JC; Humphries MJ; Bussolino F; Serini G
PLoS Biol; 2009 Jan; 7(1):e25. PubMed ID: 19175293
[TBL] [Abstract][Full Text] [Related]
8. Neuropilin-1 is required for endothelial cell adhesion to soluble vascular endothelial growth factor receptor 1.
Colotti G; Failla CM; Lacal PM; Ungarelli M; Ruffini F; Di Micco P; Orecchia A; Morea V
FEBS J; 2022 Jan; 289(1):183-198. PubMed ID: 34252269
[TBL] [Abstract][Full Text] [Related]
9. ERBB2-mediated transcriptional up-regulation of the alpha5beta1 integrin fibronectin receptor promotes tumor cell survival under adverse conditions.
Spangenberg C; Lausch EU; Trost TM; Prawitt D; May A; Keppler R; Fees SA; Reutzel D; Bell C; Schmitt S; Schiffer IB; Weber A; Brenner W; Hermes M; Sahin U; Türeci O; Koelbl H; Hengstler JG; Zabel BU
Cancer Res; 2006 Apr; 66(7):3715-25. PubMed ID: 16585198
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of transcription factor Fra-1 in ER-positive breast cancer: contribution to a metastatic phenotype through modulation of tumor cell adhesive properties.
Oliveira-Ferrer L; Kürschner M; Labitzky V; Wicklein D; Müller V; Lüers G; Schumacher U; Milde-Langosch K; Schröder C
J Cancer Res Clin Oncol; 2015 Oct; 141(10):1715-26. PubMed ID: 25666264
[TBL] [Abstract][Full Text] [Related]
11. Targeting IL13Ralpha2 activates STAT6-TP63 pathway to suppress breast cancer lung metastasis.
Papageorgis P; Ozturk S; Lambert AW; Neophytou CM; Tzatsos A; Wong CK; Thiagalingam S; Constantinou AI
Breast Cancer Res; 2015 Jul; 17(1):98. PubMed ID: 26208975
[TBL] [Abstract][Full Text] [Related]
12. Neuropilin-1 promotes the oncogenic Tenascin-C/integrin β3 pathway and modulates chemoresistance in breast cancer cells.
Naik A; Al-Yahyaee A; Abdullah N; Sam JE; Al-Zeheimi N; Yaish MW; Adham SA
BMC Cancer; 2018 May; 18(1):533. PubMed ID: 29728077
[TBL] [Abstract][Full Text] [Related]
13. CCL28 promotes breast cancer growth and metastasis through MAPK-mediated cellular anti-apoptosis and pro-metastasis.
Yang XL; Liu KY; Lin FJ; Shi HM; Ou ZL
Oncol Rep; 2017 Sep; 38(3):1393-1401. PubMed ID: 28713975
[TBL] [Abstract][Full Text] [Related]
14. Role of the kringle-like domain in glycoprotein NMB for its tumorigenic potential.
Xie R; Okita Y; Ichikawa Y; Fikry MA; Huynh Dam KT; Tran STP; Kato M
Cancer Sci; 2019 Jul; 110(7):2237-2246. PubMed ID: 31127873
[TBL] [Abstract][Full Text] [Related]
15. Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and β1-integrin signaling pathway in tumor cells.
Yuan J; Liu M; Yang L; Tu G; Zhu Q; Chen M; Cheng H; Luo H; Fu W; Li Z; Yang G
Breast Cancer Res; 2015 May; 17(1):69. PubMed ID: 25990368
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of glycoprotein nonmetastatic B and its association with HER2 in breast cancer.
Kanematsu M; Futamura M; Takata M; Gaowa S; Yamada A; Morimitsu K; Morikawa A; Mori R; Hara H; Yoshida K
Cancer Med; 2015 Sep; 4(9):1344-55. PubMed ID: 26077887
[TBL] [Abstract][Full Text] [Related]
17. Steroid receptor coactivator-1 upregulates integrin α₅ expression to promote breast cancer cell adhesion and migration.
Qin L; Chen X; Wu Y; Feng Z; He T; Wang L; Liao L; Xu J
Cancer Res; 2011 Mar; 71(5):1742-51. PubMed ID: 21343398
[TBL] [Abstract][Full Text] [Related]
18. Glycoprotein Non-Metastatic Melanoma Protein B (GPNMB) and Cancer: A Novel Potential Therapeutic Target.
Taya M; Hammes SR
Steroids; 2018 May; 133():102-107. PubMed ID: 29097143
[TBL] [Abstract][Full Text] [Related]
19. Genetic depletion and pharmacological targeting of αv integrin in breast cancer cells impairs metastasis in zebrafish and mouse xenograft models.
Li Y; Drabsch Y; Pujuguet P; Ren J; van Laar T; Zhang L; van Dam H; Clément-Lacroix P; Ten Dijke P
Breast Cancer Res; 2015 Feb; 17(1):28. PubMed ID: 25849225
[TBL] [Abstract][Full Text] [Related]
20. Integrin Subtypes and Nanoscale Ligand Presentation Influence Drug Sensitivity in Cancer Cells.
Young JL; Hua X; Somsel H; Reichart F; Kessler H; Spatz JP
Nano Lett; 2020 Feb; 20(2):1183-1191. PubMed ID: 31908168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
